Diagnosis of Hashimoto's thyroiditis and IgG4-related sclerosing disease

Pathology International

Volumn 61, Issue 4, 2011, Pages 175-183

  Kakudo, Kennichi ^a   Li, Yaqiong ^a   Hirokawa, Mitsuyoshi ^b   Ozaki, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

Autoimmune disease; Fibrosis; Hashimoto's thyroiditis; IgG4; Riedel's thyroiditis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; IMMUNOGLOBULIN G4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; RITUXIMAB; STEROID; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROTROPIN; THYROXINE; TRANSFORMING GROWTH FACTOR BETA;

ADDISON DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNE PANCREATITIS; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; HASHIMOTO DISEASE; HISTOPATHOLOGY; HYPOGONADISM; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 THYROIDITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PERNICIOUS ANEMIA; PRIORITY JOURNAL; REVIEW; RIEDEL GOITER; T LYMPHOCYTE; TH2 CELL; THYROIDITIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VITILIGO;

HASHIMOTO DISEASE; HUMANS; IMMUNOGLOBULIN G; SCLEROSIS; THYROIDITIS, AUTOIMMUNE;

EID: 79952790612     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02661.x     Document Type: Review

References (83)

1. Michels AW, Eisenbarth GS. Immunologic endocrine disorders. J Allergy Clin Immunol 2010; 125: S226-37.
2. Hamano H, Kawa S, Horiuchi A etal. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-8.
3. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008; 14: 3948-55.
4. Li Y, Bai Y, Liu Z etal. Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathol Int 2009; 59: 636-41.
5. Li Y, Nishihara E, Hirokawa M, Taniguchi E, Miyauchi A, Kakudo K. Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab 2010; 95: 1309-17.
6. Todd JA, Acha-Orbea H, Bell JI etal. A molecular basis for MHC class II-associated autoimmunity. Science 1988; 240: 1003-9.
7. Tomer Y, Huber A. The etiology of autoimmune thyroid disease: A story of genes and environment. J Autoimmun 2009; 32: 231-9.
8. Farid NR, Sampson L, Moens H, Barnard JM. The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens 1981; 17: 265-8.
9. Moens H, Farid NR, Sampson L, Noel EP, Barnard JM. Hashimoto's thyroiditis is associated with HLA-DRw3. N Engl J Med 1978; 299: 133-4.
10. Tandon N, Zhang L, Weetman AP. HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1991; 34: 383-6.
11. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y. The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): Results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) 2002; 57: 81-8.
12. Badenhoop K, Schwarz G, Walfish PG, Drummond V, Usadel KH, Bottazzo GF. Susceptibility to thyroid autoimmune disease: Molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 1990; 71: 1131-7.
13. Petrone A, Giorgi G, Mesturino CA etal. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 2001; 11: 171-5.
14. Bogner U, Badenhoop K, Peters H etal. HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity 1992; 14: 155-8.
15. Menconi F, Monti MC, Greenberg DA etal. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci U S A 2008; 105: 14034-9.
16. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006; 24: 65-97.
17. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995; 80: 41-5.
18. Donner H, Rau H, Walfish PG etal. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 143-6.
19. Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 1997; 46: 551-4.
20. Ueda H, Howson JM, Esposito L etal. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-11.
21. Nithiyananthan R, Heward JM, Allahabadia A, Franklyn JA, Gough SC. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid 2002; 12: 3-6.
22. Villanueva R, Inzerillo AM, Tomer Y etal. Limited genetic susceptibility to severe Graves' ophthalmopathy: No role for CTLA-4 but evidence for an environmental etiology. Thyroid 2000; 10: 791-8.
23. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 1998; 51: 563-6.
24. Yanagawa T, Taniyama M, Enomoto S etal. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997; 7: 843-6.
25. Criswell LA, Pfeiffer KA, Lum RF etal. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005; 76: 561-71.
26. Ban Y, Tozaki T, Taniyama M, Tomita M. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid 2005; 15: 1115-18.
27. Diamond MT, Joffe B. Monozygotic twins with chronic lymphocytic thyroiditis. (Hashimoto's disease). JAMA 1966; 198: 182-3.
28. Laurberg P. Iodine intake-what are we aiming at? J Clin Endocrinol Metab 1994; 79: 17-19.
29. Vladutiu AO, Rose NR. Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science 1971; 174: 1137-9.
30. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996; 74: 13-33.
31. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997; 26: 189-218.
32. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003; 348: 2646-55.
33. Lloyd RV, Douglas BR, Young WF, eds. Endocrine Diseases. Washington, DC: The American Registry of Pathology, 2002.
34. Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of ENDOCRINOLOGY, 11th edn. Philadelphia, PA: Saunders Elsevier, 2008.
35. Thyroiditis SPA. Acute, subacute, and chronic. Med Clin North Am 1991; 75: 61-77.
36. Tunbridge WM, Brewis M, French JM etal. Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) 1981; 282: 258-62.
37. Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 1985; 190: 147-52.
38. Hamada N, Grimm C, Mori H, DeGroot LJ. Identification of a thyroid microsomal antigen by Western blot and immunoprecipitation. J Clin Endocrinol Metab 1985; 61: 120-28.
39. Hamada N, Jaeduck N, Portmann L, Ito K, DeGroot LJ. Antibodies against denatured and reduced thyroid microsomal antigen in autoimmune thyroid disease. J Clin Endocrinol Metab 1987; 64: 230-38.
40. Rose NR, Witebsky E. Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 1956; 76: 417-27.
41. Hollowell JG, Staehling NW, Flanders WD etal. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99.
42. Hayashi N, Tamaki N, Konishi J etal. Sonography of Hashimoto's thyroiditis. J Clin Ultrasound 1986; 14: 123-6.
43. Sostre S, Reyes MM. Sonographic diagnosis and grading of Hashimoto's thyroiditis. J Endocrinol Invest 1991; 14: 115-21.
44. LiVolsi VA. The pathology of autoimmune thyroid disease: A review. Thyroid 1994; 4: 333-9.
45. Harcourt-Webster JN. Squamous epithelium in the human thyroid gland. J Clin Pathol 1966; 19: 384-8.
46. Hashimoto H. Zur Kenntnis der lymphomatöen Veränderung der Schilddrüse (Struma lymphomatosa). Arch F Klin Chir 1912; 97: 219-48.
47. Katz SM, Vickery AL Jr. The fibrous variant of Hashimoto's thyroiditis. Hum Pathol 1974; 5: 161-70.
48. Hamano H, Kawa S, Ochi Y etal. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359: 1403-4.
49. Kamisawa T, Funata N, Hayashi Y etal. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-4.
50. Zen Y, Harada K, Sasaki M etal. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: Do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004; 28: 1193-203.
51. Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 2007; 20: 884-94.
52. Cheuk W, Yuen HK, Chu SY, Chiu EK, Lam LK, Chan JK. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 2008; 32: 671-81.
53. Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T. IgG4-related disease: Historical overview and pathology of hematological disorders. Pathol Int 2010; 60: 247-58.
54. Taniguchi T, Ko M, Seko S etal. Interstitial pneumonia associated with autoimmune pancreatitis. Gut 2004; 53: 770-71; author reply 70-71.
55. Zen Y, Kitagawa S, Minato H etal. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005; 36: 710-17.
56. Sato Y, Ohshima K, Ichimura K etal. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int 2008; 58: 465-70.
57. Kitagawa S, Zen Y, Harada K etal. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's tumor). Am J Surg Pathol 2005; 29: 783-91.
58. Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant 2004; 19: 474-6.
59. Uehara T, Hamano H, Kawakami M etal. Autoimmune pancreatitis-associated prostatitis: Distinct clinicopathological entity. Pathol Int 2008; 58: 118-25.
60. Kasashima S, Zen Y, Kawashima A etal. Inflammatory abdominal aortic aneurysm: Close relationship to IgG4-related periaortitis. Am J Surg Pathol 2008; 32: 197-204.
61. Cheuk W, Chan AC, Lam WL etal. IgG4-related sclerosing mastitis: Description of a new member of the IgG4-related sclerosing diseases. Am J Surg Pathol 2009; 33: 1058-64.
62. Chan SK, Cheuk W, Chan KT, Chan JK. IgG4-related Sclerosing Pachymeningitis: A Previously Unrecognized Form of Central Nervous System Involvement in IgG4-related Sclerosing Disease. Am J Surg Pathol 2009; 33: 1249-52.
63. Miyagawa-Hayashino A, Matsumura Y, Kawakami F etal. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis-is this a cutaneous manifestation of IgG4-related disease? Hum Pathol 2009; 40: 1269-77.
64. Ghazale A, Chari ST, Smyrk TC etal. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102: 1646-53.
65. Raina A, Krasinskas AM, Greer JB etal. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: Elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med 2008; 132: 48-53.
66. Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut 2009; 58: 1680-89.
67. Li Y, Nishihara E, Kakudo K. Hashimoto's thyroiditis: Old concepts and new insights. Current Opinion Rheumatology 2011; 23: 102-07.
68. Komatsu K, Hamano H, Ochi Y etal. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci 2005; 50: 1052-7.
69. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41: 1197-205.
70. Deshpande V, Chicano S, Finkelberg D etal. Autoimmune pancreatitis: A systemic immune complex mediated disease. Am J Surg Pathol 2006; 30: 1537-45.
71. Kamisawa T, Okamoto A. Autoimmune pancreatitis: Proposal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41: 613-25.
72. Kojima M, Sipos B, Klapper W etal. Autoimmune pancreatitis: Frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol 2007; 31: 521-8.
73. Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007; 20: 23-8.
74. Vickery AL, Hamlin E, Jr. Struma lymphomatosa (Hashimoto's thyroiditis). Observations on repeated biopsies in sixteen patients. N Engl J Med 1961; 264: 226-9.
75. Hayashi Y, Tamai H, Fukata S etal. A long term clinical, immunological, and histological follow-up study of patients with goitrous chronic lymphocytic thyroiditis. J Clin Endocrinol Metab 1985; 61: 1172-8.
76. Harach HR, Williams ED. Fibrous thyroiditis-an immunopathological study. Histopathology 1983; 7: 739-51.
77. Hay ID. Thyroiditis: A clinical update. Mayo Clin Proc 1985; 60: 836-43.
78. Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med 1967; 66: 884-92.
79. Beahrs OH, McConahey WM, Woolner LB. Invasive fibrous thyroiditis (Riedel's struma). J Clin Endocrinol Metab 1957; 17: 201-20.
80. Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: Report and characterisation of a new disease. BMC Med 2006; 4: 23.
81. Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH. Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) 2010; 62: 1312-18.
82. Zen Y, Fujii T, Harada K etal. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007; 45: 1538-46.
83. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62: 1755-62.